Tauro 6-ethlchenodeoxycholic acid-d5 (sodium)
Tauro 6-ethlchenodeoxycholic acid-d5 sodium is deuterium labeled Tauro-obeticholic acid. Tauro-obeticholic acid is an active metabolite of Obeticholic acid. Obeticholic acid is an orally bioavailable farnesoid-X receptor (FXR) agonist[1].
Product Specifications
UNSPSC
12352211
Target
FXR; Isotope-Labeled Compounds
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
OC1CC[C@]2([C@@]([H])(C1)[C@H]([C@H]([C@@]3([C@@]2(CC[C@]4([C@]3(CC[C@@]4([C@H](C)CCC(NCCS(=O)(O[Na])=O)=O)[H])[H])C)[H])[H])O)C([2H])(C([2H])([2H])[2H])[2H])C
Molecular Formula
C28H43D5NNaO6S
Molecular Weight
554.77
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Markham A, et al. Obeticholic Acid: First Global Approval. Drugs. 2016 Aug;76 (12) :1221-6.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740034-500 1x 500 µL
Cytokeratin 8/18 (C-51), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941218-500 1x 500 µL
CELA3B (CELA3B/1218), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401471-500 1x 500 µL
Vitronectin Receptor / CD51 / CD61 (23C6), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402307-100 1x 100 µL
Moesin (rMSN/492), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401908-100 1x 100 µL
PAX5 / BSAP (Early B-Cell Marker) (PCRP-PAX5-1B7), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details